Fulgent Genetics, Inc. (FLGT) Financials

FLGT Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 1.2 billion 112.2 million
Dec. 31, 2025 1.2 billion 106.8 million
Sept. 30, 2025 1.2 billion 93.8 million
June 30, 2025 1.2 billion 88.2 million

FLGT Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 1.9 million 9.9 million
Dec. 31, 2025 -83.1 million 9.3 million
Sept. 30, 2025 5.1 million 9.7 million
June 30, 2025 -37.0 million 10.0 million

FLGT Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 -24.8 million
Dec. 31, 2025 -23.7 million
Sept. 30, 2025 -6.8 million
June 30, 2025 -19.3 million

FLGT Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 276.3 million 1.5 million 6.0 million
Dec. 31, 2025 336.1 million 2.0 million 5.2 million
Sept. 30, 2025 375.8 million 2.0 million 5.1 million
June 30, 2025 292.9 million 2.0 million 5.0 million

FLGT Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 30.9 million
Dec. 31, 2025 30.8 million
Sept. 30, 2025 30.7 million
June 30, 2025 30.8 million

FLGT Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 5.2 million 14.2 million 39.9 million -
Dec. 31, 2025 5.0 million 14.2 million 52.6 million 11.0 million
Sept. 30, 2025 6.1 million 13.9 million 35.0 million 11.6 million
June 30, 2025 6.8 million 13.5 million 38.7 million 12.3 million

FLGT Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 71.1 million 51.7 million
Dec. 31, 2025 83.3 million 50.8 million
Sept. 30, 2025 84.1 million 48.6 million
June 30, 2025 81.8 million 47.4 million

FLGT Revenue by Segment
Graph available only for paid members. Upgrade to see it.

FLGT

Price: $19.88

52 week price:
13.46
31.04

Earnings Per Share: -2.40 USD

Exchange: NGM

Sector: Healthcare

Industry: Diagnostics & Research

Country: United States

Volume: 235500

Ebitda: -1.0 million

Market Capitalization: 592.2 million

Links: